Related Experiment Video
Updated: Jun 21, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Myelodysplastic/myeloproliferative neoplasms.
1Department of Pathology, University of New Mexico, Health Sciences Center, TriCore Reference Laboratory, 1001 Woodward Pl NE, Albuquerque, NM 87102, USA.
American Journal of Clinical Pathology
|July 17, 2009
Summary
Myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) present diagnostic challenges due to overlapping features with other myeloid disorders. Current classifications require refinement for accurate subtyping and clinical management of these rare conditions.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Myelodysplastic/myeloproliferative neoplasms (MDS/MPNs) are rare myeloid neoplasms with combined dysplastic and proliferative characteristics.
- Accurate classification is crucial for understanding disease biology and guiding treatment strategies.
Observation:
- Diagnostic difficulties arise from the significant overlap between MDS/MPNs and other myeloid neoplasms, including chronic myeloproliferative neoplasms and myelodysplasia.
- Distinguishing MDS/MPNs from acute myeloid leukemias is challenging, particularly in the consistent identification of blast equivalents like promonocytes.
Findings:
- Genetic markers for specific MDS/MPN subtypes remain largely unidentified, with the exception of juvenile myelomonocytic leukemia.
- The 2008 World Health Organization classification shows minimal revisions for MDS/MPNs compared to the 2001 version, reflecting ongoing classification challenges.
Implications:
- Further research is needed to identify specific genetic drivers for MDS/MPN subtypes.
- Improved diagnostic criteria and classification are essential for advancing the management of patients with MDS/MPNs.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:21Lineage Commitment
Commitment is the process whereby stem cells: